Advancing the Science of Cancer in Latinos

Name: Advancing the Science of Cancer in Latinos
ISBN: 9783031144387

Lingua: inglese

Editore: Springer International Publishing, 2022

3031144384 / 9783031144387

Brossura
Nuovo

Visualizza tutti i dettagli

Da: moluna, Greven, Germaniamoluna

Venditore con 5 stelle

Venditore AbeBooks dal 9 luglio 2020

Visualizza gli articoli di questo venditore

Brossura

Condizione: Nuovo

EUR 39,60

EUR 48,99 spedizione

Spedito da Germania a U.S.A.

Quantità: Più di 20 disponibili

Aggiungi al carrello

Resi gratuiti per 30 giorni

Lista dei preferitiCrea un desiderata per articoli simili

Descrizione dell’articolo da parte del venditore

Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Summarizes outcomes of the 2nd international conference on Advancing the Science of Cancer in LatinosFeatures research from leading experts and identifies priority research areas in Latino cancer health disparitiesIs a resource for physicia.

Codice articolo 668447796

Contatta il venditore per questo articolo

Segnala questo articolo

Titolo: Advancing the Science of Cancer in Latinos
Editore: Springer International Publishing
Anno di pubblicazione: 2022
Condizione: New
Rilegatura: Kartoniert / Broschiert
Lingua: inglese
ISBN 10: 3031144384
ISBN 13: 9783031144387
Cataloghi dei venditori: Mathematik/Naturwissenschaften/Technik/Medizin

This open access book is a collection of articles based on presentations from the 2020 Advancing the Science of Cancer in Latinos conference that gives an overview of conference outcomes. The vision of the conference has been to unite researchers, scientists, physicians and other healthcare professionals, patient advocates, and students from across the world to discuss research advancements, identify gaps, and develop actionable goals to translate basic research findings into clinical best practices, effective community interventions, and professional training programs to decrease cancer risks and eliminate cancer disparities for Latinos. This conference comes at an especially important time when Latinos – the largest and youngest minority group in the U.S. – are expected to face a 142% rise in cancer cases in the coming years. Disparities continue to impact this population in critical areas: access to preventive and clinical care, changeable risk behaviors, quality of life, and mortality.

Each chapter summarizes the presentation and includes current knowledge in the specific topic areas, identified gaps, and opportunities for future research. Topics explored include:

Applying an Exposome-Wide (ExWAS) Approach to Latino Cancer Disparities
Supportive Care Needs and Coping Strategies Used by Latino Men Cancer Survivors
Optimizing Engagement of the Latino Community in Cancer Research
Latino Population Growth and the Changing Demography of Cancer
Implementation Science to Enhance the Value of Cancer Research in Latinos
A Strength-Based Approach to Cancer Prevention in Latinxs
Overcoming Clinical Research Disparities by Advancing Inclusive Research

Advancing the Science of Cancer in Latinos: Building Collaboration for Action will appeal to a wide readership due to its comprehensive coverage of topics ranging from basic science andcommunity prevention research to clinical practice to policy. The book is an essential resource for physicians and other medical professionals, researchers, scientists, academicians, patient advocates, and students. It also will appeal to policy-makers, NCI-designated cancer centers, academic centers, state health departments, and community organizations.

"Riassunto" può appartenere a un’altra edizione di questo titolo.

Informazioni sull’autore

?Amelie G. Ramirez, DrPH, an internationally recognized cancer and chronic disease health disparities and health promotion researcher, is chair and professor of population health sciences at UT Health San Antonio, where she also is founding director of the Institute for Health Promotion Research and associate director of cancer outreach and engagement at the Mays Cancer Center at UT Health San Antonio, an NCI-designated cancer center.

Over the past 30 years, Dr. Ramirez has directed over 100 research programs focused on human and organizational communication to reduce chronic disease and cancer health disparities affecting Latinos and other minority and underserved populations, including cancer risk factors, clinical trial recruitment, patient navigation, tobacco prevention, obesity prevention, and more. Dr. Ramirez directs two national research networks, one funded by the National Cancer Institute targeting Latino cancer (Redes En Acción, redesenaccion.com) and one funded by the Robert Wood Johnson Foundation promoting health equity through community change for Latino health equity (Salud America!, salud-america.org/; @SaludAmerica on social media). Salud America! has a network of more than 300,000 community leaders, school personnel, parents, and healthcare professionals and researchers who are fueled with educational content and tools to advocate for equitable changes in policies, systems, and environments in Latino communities. Salud America!’s core network members have produced 179 Latino childhood health policy wins (something passed by a relevant voting body), according to a 2018 evaluation report. Dr. Ramirez also has led studies using the latest mobile technologies—mobile phone apps, text messaging programs, and social media innovations, etc.—to improve health behaviors among Latinos, covering issues from smoking cessation to breast cancer treatment adherence.

Dr. Ramirez also understands the great need for mentorship programs and diversity in the research field. She has personally trained and/or mentored over 300 Latino undergraduate and pre- and post-doctoral students, as well as early-career faculty members, instructing about research design, methods, data analysis, and career development. Many of her trainees have achieved high profile and broad-reaching independent success, including K01 awards. She also directs Éxito! Latino Cancer Research Leadership Training, an NCI-funded project to train and encourage Latino master’s-level students and professionals to pursue a doctoral degree and cancer research career. Of 175 Éxito! grads since 2011, more than 35% have applied to doctoral programs and more than 20% are now enrolled in a doctoral program (or have graduated). Dr. Ramirez also united over 225 Latino cancer disparities researchers for the first-ever “Advancing the Science of Cancer in Latinos” conference in February 2018 to focus specifically on cancer health disparities among Latino communities, as well as a second “Advancing the Science of Cancer in Latinos” conference in February 2020.

Dr. Ramirez has authored many peer-reviewed articles, is an editorial board member on several prestigious journals, including Health Education Research, and is frequently invited to speak at scientific meetings. She has been recognized for her work to improve Latino health and advance Latinos in medicine, public health, and behavioral sciences across the U.S., including: 2019 Lifetime Achievement Award from the Society of Behavioral Medicine; 2018 CentroMed Icons in Healthcare Award; 2014 Everett M. Rogers Public Health Communication Award from APHA; 2014 Making a Difference Award from Latinas Contra Cancer; 2011 White House “Champion of Change”; 2009 Health Care Hero from the San Antonio Business Journal; 2007 election to the National Academy of Medicine (formerly the Institute of Medicine); and 2007 Professor of Survivorship from Susan G. Komen For the Cure. She also is a 2018 Susan G. Komen Scholar and a member of the National Advisory Council on Minority Health and Health Disparities (NACMHD) of the National Institute on Minority Health and Health Disparities (NIMHD). In Texas, Dr. Ramirez is on the San Antonio Mayor’s Fitness Council and is Board President of The Academy of Medicine, Engineering and Science of Texas. Dr. Ramirez is a native of Laredo, Texas. She received a B.S. from The University of Houston and M.P.H. and Dr.P.H. degrees from The University of Texas Health Science Center at Houston School of Public Health.

Edward J Trapido, ScD, FACE, is Professor and Wendell Gauthier Chair for Cancer Epidemiology at the LSU School of Public Health and the Stanly S. Scott Cancer Center (SSSCC), where he leads initiatives in cancer control and etiologic research. He directs the Louisiana Cancer Research Consortium (LCRC) Population Sciences research program, a joint initiative involving the SSSCC, the Tulane Cancer Center, and Xavier University. Dr. Trapido also serves as the Deputy Director for the Stanley S. Scott Cancer Center. Focused on strengthening interdepartmental research at the LSU Health Sciences Center, Dr. Trapido serves as senior advisor to the deans of school of public health and of medicine. Prior to joining LSU, he was Professor and Acting Division Director for the Department of Epidemiology and Public Health at the University of Miami School of Medicine, where he also directed the doctoral program in Epidemiology, the HIV-AIDS Surveillance Program, and the Global Research and Evaluation Center. His leadership experience includes appointments at the NCI as Deputy Director for International Cancer Control in the Office of International Affairs and as Associate Director of the Epidemiology and Genetics Research Program within the Division of Cancer Control and Population Sciences. In addition, he has co-chaired of the Trans-NIH Tobacco and Nicotine Research Interest Group and served as Senior Advisor to the Director of the International Agency for Research, in Lyon, France. He has been a member of the steering committee for the 2006 NIH State-of-the-Science Statement on Tobacco Use: Prevention, Cessation and Control, which was part of the NIH Consensus Development Program and of the National Academy of Sciences/Institute of Medicine Committee on Secondhand Smoke Exposure and Acute Coronary Events. His degrees include a Master’s in parasitology from the University of North Carolina, and both a Master's and Doctor of Science in Epidemiology from Harvard. Prior to joining the faculty at the University of Miami, Dr. Trapido was a staff fellow in the Division of Cancer Etiology at the NCI and, before that, as instructor in environmental health and community medicine at New York's Downstate Medical Center. His primary areas of research interest are tobacco prevention, cancer prevention and control, especially in minority and underserved populations, and program evaluation.

"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.

moluna

Greven, Germania

Venditore con 5 stelle

Venditore AbeBooks dal 9 luglio 2020

Tariffe di spedizione da Germania a U.S.A.

Articolo	Da 26 a 60 giorni lavorativi	Da 26 a 60 giorni lavorativi
Primo articolo	EUR 48,99	EUR 48,99

I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.

Metodi di pagamento

Assegno
Bonifico bancario
PayPal

Descrizione dello Store

Online Handel nur mit Neubüchern

Informazioni sull’azienda del venditore

Moluna GmbH

Engberdingdamm 27
Greven, Germania 48268

Contatta il venditoreVisualizza gli articoli di questo venditoreVisita la vetrina del venditore

Condizioni di vendita

Editoriale

Riconoscimento legale degli offerenti:

Moluna GmbH
rappresentata dall'amministratore Helge Blischke
Engberdingdamm 27
48268 Greven
Germania
Telefono: 02571/5698933
Fax: 02571/5698930
E-Mail: abe@moluna.de
P. IVA: DE296281834
iscritta nel registro delle imprese del tribunale Steinfurt
numero di registro delle imprese HRB 10553

Siamo membri dell’iniziativa “FairCommerce” dal 24.07.2015.
Per ulteriori informazioni, vedere www.haendlerbund.de/faircommerce.

Diritto di recesso

Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.

Informazioni sul diritto di recesso

Diritto legale di recesso

Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.

Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.

Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).

Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.

Effetti del recesso

In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).

Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.

Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.

Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.

Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.

Dovrai rispedire i beni o consegnarli a moluna, Greven, Germany, senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.

Eccezioni al diritto di recesso

Il diritto di recesso non si applica a:

La fornitura di giornali, periodici o riviste ad eccezione dei contratti di abbonamento; e
La fornitura di contenuto digitale non fornito su un supporto materiale (ad es. su un CD o DVD), se al momento dell'invio dell'ordine hai accettato l'inizio dell'esecuzione e hai riconosciuto che non avresti potuto recedere una volta iniziata l'esecuzione.